IL96943A - Pharmaceutical compositions for ophthalmic administration comprising a combination of hyaluronic acid fractions and ophthalmic drugs
- Google Patents
Pharmaceutical compositions for ophthalmic administration comprising a combination of hyaluronic acid fractions and ophthalmic drugs
Info
Publication number
IL96943A
IL96943AIL96943AIL9694384AIL96943AIL 96943 AIL96943 AIL 96943AIL 96943 AIL96943 AIL 96943AIL 9694384 AIL9694384 AIL 9694384AIL 96943 AIL96943 AIL 96943A
Authority
IL
Israel
Prior art keywords
ophthalmic
combination
pharmaceutical compositions
hyaluronic acid
acid fractions
Prior art date
Application number
IL96943A
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT48979/84Aexternal-prioritypatent/IT1178041B/en
Application filed by Fidia SpafiledCriticalFidia Spa
Priority claimed from IL73217Aexternal-prioritypatent/IL73217A/en
Publication of IL96943ApublicationCriticalpatent/IL96943A/en
IL96943A1984-10-091984-10-10Pharmaceutical compositions for ophthalmic administration comprising a combination of hyaluronic acid fractions and ophthalmic drugs
IL96943A
(en)
Non-inflammatory hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
Process for producing new pharmaceutically active 5-fluoro-2-///4-/cyclopropyl-methoxy/-2-pyridinyl/-methyl-sulfonyl/-1h-benzimidazol and pharmaceutical compositions containing them
Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis